Trinity Biotech PLC (TRIB)
2.47
-0.12
(-4.63%)
USD |
NASDAQ |
Jun 20, 16:00
2.475
0.00 (0.00%)
After-Hours: 20:00
Trinity Biotech Gross Profit (TTM): 19.40M for March 31, 2024
Gross Profit (TTM) Chart
Historical Gross Profit (TTM) Data
Date | Value |
---|---|
March 31, 2024 | 19.40M |
December 31, 2023 | 19.45M |
September 30, 2023 | 20.26M |
June 30, 2023 | 16.31M |
March 31, 2023 | 16.86M |
December 31, 2022 | 17.27M |
September 30, 2022 | 14.51M |
June 30, 2022 | 23.08M |
March 31, 2022 | 28.52M |
December 31, 2021 | 33.45M |
September 30, 2021 | 46.50M |
June 30, 2021 | 54.37M |
March 31, 2021 | 50.22M |
December 31, 2020 | 48.58M |
September 30, 2020 | 42.20M |
June 30, 2020 | 35.49M |
March 31, 2020 | 38.06M |
December 31, 2019 | 38.12M |
September 30, 2019 | 39.08M |
June 30, 2019 | 38.99M |
March 31, 2019 | 40.36M |
December 31, 2018 | 41.45M |
September 30, 2018 | 41.41M |
June 30, 2018 | 42.42M |
March 31, 2018 | 42.44M |
Date | Value |
---|---|
December 31, 2017 | 41.90M |
September 30, 2017 | 41.19M |
June 30, 2017 | 41.86M |
March 31, 2017 | 42.85M |
December 31, 2016 | 43.09M |
September 30, 2016 | 44.38M |
June 30, 2016 | 44.70M |
March 31, 2016 | 44.28M |
December 31, 2015 | 46.24M |
September 30, 2015 | 47.17M |
June 30, 2015 | 48.20M |
March 31, 2015 | 49.32M |
December 31, 2014 | 49.38M |
September 30, 2014 | 50.31M |
June 30, 2014 | 49.28M |
March 31, 2014 | 47.21M |
December 31, 2013 | 45.22M |
September 30, 2013 | 43.13M |
June 30, 2013 | 41.79M |
March 31, 2013 | 42.08M |
December 31, 2012 | 42.25M |
September 30, 2012 | 42.03M |
June 30, 2012 | 41.65M |
March 31, 2012 | 40.91M |
December 31, 2011 | 40.13M |
Gross Profit Definition
Gross profit is the difference between sales and the cost of goods sold. Revenues (aka Sales) less Cost of Goods Sold (COGS) is a company's gross profit. For many companies, cost of goods sold is a substantial portion of expenses.
Gross Profit (TTM) Range, Past 5 Years
14.51M
Minimum
Sep 2022
54.37M
Maximum
Jun 2021
32.03M
Average
34.47M
Median
Gross Profit (TTM) Benchmarks
Amarin Corp PLC | 149.52M |
Avadel Pharmaceuticals PLC | 52.77M |
Medtronic PLC | 21.15B |
Perspective Therapeutics Inc | -- |
Xtant Medical Holdings Inc | 62.23M |